IL32 and cancer: To determine whether PCs regulated Src‐Akt signaling in cancer cells via IL32‐β5‐integrin paracrine signaling, we treated cancer cells with CM from PCs transfected IL32 targeting siRNA or siNSC in the presence/absence of TKI drugs.